Semaglutide linked to 40% reduction in asthma attacks

A study reports that semaglutide, used for diabetes and obesity, is associated with a 40% reduction in asthma attacks. The finding is based on observational data, and causality is not established. This could expand the drug's therapeutic use and impact healthcare costs.